Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start" with more than 3,500 healthcare ...
Berenberg Bank analyst Luisa Hector maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.00.
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Hosted on MSN23h
China’s NMPA approves GSK’s Nucala for CRSwNP treatmentThe China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback